Author(s):
S. Venkateswara Rao, S. Sathesh Kumar
Email(s):
sathesh2000@gmail.com
DOI:
10.52711/0974-360X.2021.00782 
Address:
S. Venkateswara Rao1, S. Sathesh Kumar*2
1Department of Pharmaceutics, Vel’s Institute of Science, Technology and Advanced Studies (VISTAS), Vel’s University, Chennai – 600117, Tamilnadu, India.
2School of Pharmaceutical Sciences, Vel’s Institute of Science, Technology and Advanced Studies (VISTAS), Vel’s University, Chennai – 600117, Tamilnadu, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 8,
Year - 2021
ABSTRACT:
Flutamide is a potent nonsteroidal anti androgen used to treat advanced prostate cancer. It blocks the androgen receptors on the cancer cells and inhibits the androgen dependent cell growth. This work was planned to compile the research work available in the scientific publications in the formulation and evaluation of Flutamide loaded polymeric nanoparticles for the treating the prostate cancer including the study of influence of various formulation components such as polymer concentration, organic phase volume, drug content, stabilizer concentrations and the ratio between aqueous to organic phase in the characteristics of nanoparticles. Literature study revealed that, methods like Ionic Gelation Technique, Solvent Evaporation method and Nanoprecipitation have been utilized and polymers like Chitosan, casein, Methacrylic acid, PHEA-IB-p(BMA) graft copolymer, mPEG – PLGA and PVA have been utilized. The drug loaded polymeric nanoparticles were evaluated for their physiocochemical properties along with characterization with FTIR, in vitro release and in vitro and in vivo anticancer potential. From the literature it was understood that, nanoprecipitation method was the most commonly used method in various research perspectives. Based on the findings of the present review, Flutamide loaded polymeric nanoparticles may be used as an treatment adjunctive for prostate cancer.
Cite this article:
S. Venkateswara Rao, S. Sathesh Kumar. Flutamide Loaded Polymeric Nanoparticles for prostate Cancer: A Review. Research Journal of Pharmacy and Technology. 2021; 14(8):4501-3. doi: 10.52711/0974-360X.2021.00782
Cite(Electronic):
S. Venkateswara Rao, S. Sathesh Kumar. Flutamide Loaded Polymeric Nanoparticles for prostate Cancer: A Review. Research Journal of Pharmacy and Technology. 2021; 14(8):4501-3. doi: 10.52711/0974-360X.2021.00782 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-8-88
REFERENCES:
1. J. Ferlay, H.R. Shin and F. Bray. Cancer Incidence and Mortality Worldwide: IARC Cancer Base. International Agency for Research on Cancer. 2010; 45 - 66
2. Beiki O. Cancer and migration: Epidemiological studies on relationship between country of birth, socio-economic position and cancer. 2010; 22 - 35
3. Prakash Galani. Diagnosis and Prognosis of Prostate Cancer. Journal of Advanced Medical and Dental Sciences Research. 2015; Vol. 3: 49 – 53
4. Shalu Jain, Sunita Saxena and Anup Kumar. Epidemiology of prostate cancer in India. Meta Zene. 2014; Vol. 2: 596 – 605
5. Melrose Park, Australian Pharmaceutical Formulary and Handbook. 19th ed. 2004; 105
6. The United Stated Pharmacopeia. 27th ed. Rockville, United States Pharmacopeial Convention, 2004; 2: 837-838
7. Zuo Z, Tam YK, Diakur J, Wiebe LI. Hydroxypropyl-β-cyclodextrin flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in rat. J Pharm Pharmaceut Sci. 2002; 5: 292–298.
8. British Pharmacopoeia London, The Stationary Office. 2004; Vol. 1: 864-5.
9. Umrethia M.L, Ghosh P.K, Majithiya R.J. and Murthy R.S.R., Pharmacokinetics and hepatotoxicity of flutamide liposomes after IV administration, Online J. Pharmaco. 2005; Vol. 3: 1-15.
10. Adlin Jino Nesalin J, Gowthamarajan K and Somashekhara C.N. Formulation and evaluation of Nanoparticles containing flutamide. International Journal of Chem Tech Research. 2009; Vol. 1: 1331 – 1334
11. Ahmed O Elzoghby, Maged W Helmy, Wael M Samy, Nazik A Elgindy. Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics. International Journal of Nanomedicine. 2013; Vol.8: 1721–1732
12. K. Umasankar and c. Umamaheswar Reddy. Nanoparticular Drug Delivery System of Anticancer Drug – Flutamide. International Journal of Pharm Tech Research. 2010; Vol. 4: 1115
13. Mariano Licciardi, Cinzia Scialabba, Calogero Fiorica, Gennara Cavallaro, Giovanni Cassata, and Gaetano Giammona. Polymeric nanocarriers for magnetic targeted drug delivery: preparation, characterization, and in vitro and in vivo evaluation. Mol. Pharmaceutics. 2013: Vol.10: 4397–4407
14. Dipsingh SN. Preparation and in vitro–in vivo evaluation of surface-modified poly(lactide-coglycolide) nanoparticles as controlled release carriers for flutamide delivery. Journal of Microencapsulation. 2015; Vol. 32: 231 – 239
15. R. S. Surenya, Snima, K. S., V Shantikumar, N., and Lakshmanan, V. Kumar, “Assessment of Poly (vinyl alcohol) Coated Flutamide Nanoparticulates and Their Efficacy on Prostate Cancer Cells.”, Curr Drug Deliv, 2016; Vol. 2: 312 - 339
16. VJ Mohanraj and Y Chen. Nanoparticles – A Review. Tropical Journal of Pharmaceutical Research, 2006; Vol. 5: 561-573
17. Nagavarma B V N, Hemant K.S. Yadav, Ayaz A, Vasudha L.S and Shivakumar H.G. Different techniques for preparation of polymeric nanoparticles - A review. Asian J Pharm Clin Res, 2012; Vol. 5: 16-23
18. Y. Dastagiri Reddy, D. Dhachinamoorthi and K. B. Chandra Sekhar. A Brief Review on Polymeric Nanoparticles for Drug Delivery and Targeting. Journal of Medical and Pharmaceutical Innovation. 2015; Vol. 2: 19-32